Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response

Elke Malzer1, Marie-Louise Daly, Aileen Moloney

  • 1Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research (CIMR), Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.

Insights

The integrated stress response (ISR) links cell stress to cell cycle arrest via PERK and CHK1. This discovery reveals how cells halt proliferation during misfolded protein stress.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • The integrated stress response (ISR) is crucial for cellular protection against stress.
  • The ISR's role in solid tumor growth and its precise mechanisms influencing cellular proliferation remain incompletely understood.
  • A model for studying ISR signaling and its impact on tissue growth was needed.

Purpose of the Study:

  • To investigate the effects of ISR signaling on cellular proliferation and tissue growth.
  • To identify key molecular players mediating the ISR's influence on the cell cycle.

Main Methods:

  • Developed a model of ISR signaling using Drosophila melanogaster.
  • Utilized genetic screening of transposon insertions to identify relevant genes.
  • Employed RNA interference (RNAi) for gene knockdown.
  • Investigated checkpoint kinase 1 (CHK1) activation in mammalian cells.

Main Results:

  • Overexpression of the ISR kinase PERK in Drosophila caused an atrophic eye phenotype, rescued by GADD34.
  • A genetic screen identified 'grapes,' the Drosophila CHK1 orthologue.
  • Knockdown of grapes/CHK1 rescued eye development despite PERK activation.
  • PERK activation was necessary and sufficient for CHK1 activation and G2 cell cycle delay in mammalian cells.

Conclusions:

  • Non-genotoxic misfolded protein stress engages DNA-damage-induced cell cycle checkpoints.
  • The ISR couples cellular stress responses to cell cycle arrest through the PERK-CHK1 pathway.
  • This mechanism provides a link between protein misfolding, stress response, and proliferation control.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...